東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/07 | 1,893 | 1,907 | 1,892 | 1,896 | +8 | +0.4% | 46,700 |
2023/04/06 | 1,885 | 1,892 | 1,871 | 1,888 | +2 | +0.1% | 69,000 |
2023/04/05 | 1,930 | 1,933 | 1,886 | 1,886 | -54 | -2.8% | 72,300 |
2023/04/04 | 1,923 | 1,940 | 1,913 | 1,940 | +24 | +1.3% | 87,300 |
2023/04/03 | 1,902 | 1,928 | 1,902 | 1,916 | +21 | +1.1% | 77,400 |
2023/03/31 | 1,889 | 1,904 | 1,881 | 1,895 | +11 | +0.6% | 54,800 |
2023/03/30 | 1,889 | 1,900 | 1,879 | 1,884 | -34 | -1.8% | 75,800 |
2023/03/29 | 1,913 | 1,921 | 1,898 | 1,918 | +18 | +0.9% | 118,600 |
2023/03/28 | 1,916 | 1,916 | 1,897 | 1,900 | -4 | -0.2% | 65,800 |
2023/03/27 | 1,890 | 1,904 | 1,880 | 1,904 | +26 | +1.4% | 74,300 |
2023/03/24 | 1,846 | 1,881 | 1,842 | 1,878 | +27 | +1.5% | 78,700 |
2023/03/23 | 1,847 | 1,852 | 1,831 | 1,851 | -8 | -0.4% | 91,100 |
2023/03/22 | 1,872 | 1,875 | 1,851 | 1,859 | +9 | +0.5% | 69,700 |
2023/03/20 | 1,863 | 1,876 | 1,850 | 1,850 | -26 | -1.4% | 65,200 |
2023/03/17 | 1,878 | 1,882 | 1,871 | 1,876 | +11 | +0.6% | 88,700 |
2023/03/16 | 1,850 | 1,870 | 1,838 | 1,865 | -9 | -0.5% | 89,800 |
2023/03/15 | 1,880 | 1,885 | 1,864 | 1,874 | +6 | +0.3% | 102,400 |
2023/03/14 | 1,875 | 1,878 | 1,840 | 1,868 | -26 | -1.4% | 179,100 |
2023/03/13 | 1,908 | 1,911 | 1,881 | 1,894 | -33 | -1.7% | 137,100 |
2023/03/10 | 1,931 | 1,952 | 1,927 | 1,927 | -22 | -1.1% | 133,800 |
2023/03/09 | 1,918 | 1,950 | 1,916 | 1,949 | +37 | +1.9% | 127,400 |
2023/03/08 | 1,906 | 1,919 | 1,892 | 1,912 | +6 | +0.3% | 90,900 |
2023/03/07 | 1,900 | 1,910 | 1,900 | 1,906 | -1 | -0.1% | 62,300 |
2023/03/06 | 1,929 | 1,931 | 1,897 | 1,907 | -9 | -0.5% | 130,700 |
2023/03/03 | 1,885 | 1,916 | 1,880 | 1,916 | +48 | +2.6% | 146,200 |
2023/03/02 | 1,897 | 1,900 | 1,866 | 1,868 | -25 | -1.3% | 161,400 |
2023/03/01 | 1,915 | 1,918 | 1,893 | 1,893 | -22 | -1.1% | 143,000 |
2023/02/28 | 1,929 | 1,931 | 1,914 | 1,915 | -15 | -0.8% | 153,400 |
2023/02/27 | 1,892 | 1,931 | 1,882 | 1,930 | +33 | +1.7% | 211,000 |
2023/02/24 | 1,918 | 1,918 | 1,892 | 1,897 | -14 | -0.7% | 127,800 |
2023/02/22 | 1,915 | 1,920 | 1,898 | 1,911 | -18 | -0.9% | 105,600 |
2023/02/21 | 1,902 | 1,932 | 1,897 | 1,929 | +21 | +1.1% | 112,300 |
2023/02/20 | 1,916 | 1,919 | 1,903 | 1,908 | +6 | +0.3% | 63,700 |
2023/02/17 | 1,919 | 1,922 | 1,902 | 1,902 | -26 | -1.3% | 103,600 |
2023/02/16 | 1,938 | 1,949 | 1,927 | 1,928 | -1 | -0.1% | 74,800 |
2023/02/15 | 1,950 | 1,951 | 1,913 | 1,929 | -13 | -0.7% | 119,300 |
2023/02/14 | 1,950 | 1,951 | 1,904 | 1,942 | -30 | -1.5% | 239,600 |
2023/02/13 | 1,985 | 1,986 | 1,960 | 1,972 | -14 | -0.7% | 98,100 |
2023/02/10 | 1,990 | 2,003 | 1,985 | 1,986 | -9 | -0.5% | 55,100 |
2023/02/09 | 1,998 | 2,013 | 1,991 | 1,995 | -7 | -0.3% | 46,400 |
2023/02/08 | 2,003 | 2,015 | 1,995 | 2,002 | -1 | ±0% | 54,700 |
2023/02/07 | 2,005 | 2,008 | 1,997 | 2,003 | +7 | +0.4% | 24,100 |
2023/02/06 | 1,999 | 2,005 | 1,992 | 1,996 | -3 | -0.2% | 41,100 |
2023/02/03 | 2,003 | 2,011 | 1,987 | 1,999 | -13 | -0.6% | 66,900 |
2023/02/02 | 2,032 | 2,033 | 2,011 | 2,012 | -19 | -0.9% | 56,600 |
2023/02/01 | 2,059 | 2,059 | 2,030 | 2,031 | -17 | -0.8% | 42,100 |
2023/01/31 | 2,033 | 2,054 | 2,031 | 2,048 | +16 | +0.8% | 48,600 |
2023/01/30 | 2,026 | 2,048 | 2,026 | 2,032 | +8 | +0.4% | 56,500 |
2023/01/27 | 2,050 | 2,050 | 2,022 | 2,024 | -16 | -0.8% | 42,800 |
2023/01/26 | 2,040 | 2,045 | 2,029 | 2,040 | -4 | -0.2% | 39,100 |
401~
450
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム